Global Pulmonary Drug Delivery Devices Market Report By Product (Metered Dose Inhalers,Dry Powder Inhalers,Nebulizers,Accessories), By Application (Asthma,Cystic Fibrosis,COPD,Allergic Rhinitis,Others), By Distribution Channel (Retail Pharmacies,Hospital Pharmacies,E-Commerce), By End-Use (Hospitals & Clinics,Homecare) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2020-2027

ID:VMR11213860
April 2021
Report Formats:
The global demand for Pulmonary Drug Delivery Devices Market is presumed to reach the valuation of nearly USD XX MN by 2027 from USD XX MN in 2020 with a CAGR of XX% under the study period of 2020 - 2027. 

Pulmonary drug delivery devices are devices used for delivering drug formulation through the mouth by inhalation. The inhaled drug deposits in the lower airways treat pulmonary diseases like bronchial asthma and cystic fibrosis. These devices fall under three different classes, like metered-dose inhalers, nebulizers, and dry powder inhalers. The delivery mechanism chosen depends on the type of drug formulation, the site of action, and the lungs' pathophysiology. Relatively small amounts of molecules are used to deliver substantial drug quantities to the target when using these devices. Smart devices providing real-life objective information about a patient's adherence patterns and their inhaler technique are available. 

Market Dynamics

The critical growth inducer for the pulmonary drug delivery devices market is the growing incidences of chronic respiratory disorders like tuberculosis, bronchitis, pneumonia, and asthma. Low efficacy of traditional treatment methods and better penetrability of drugs when using these devices will benefit market growth. Continued research and development to formulate new drugs and innovative delivery mechanisms to ensure minimal dosage will boost the market growth. The rising geriatric population and increased preference for minimally invasive treatment options will be a market booster. Rapid growth in the e-commerce sector will expand the growth of this market. Low drug absorption and enzymatic instability witnessed when using these devices will hinder the development of this market.

The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.

Additionally, these tools also give inclusive assessment of each segment in the global market of pulmonary drug delivery devices.

Market Segmentation

This section of the pulmonary drug delivery devices market report  provides detailed data on the segments by analyzing them geographically, thereby assisting the strategist in identifying the target demographics for the respective product or service.

By Product
  • Metered Dose Inhalers
  • Dry Powder Inhalers
  • Nebulizers
  • Accessories

By Application
  • Asthma
  • Cystic Fibrosis
  • COPD
  • Allergic Rhinitis
  • Others

By Distribution Channel
  • Retail Pharmacies
  • Hospital Pharmacies
  • E-Commerce

By End-Use
  • Hospitals & Clinics
  • Homecare

Regional Analysis

This section covers regional segmentation which accentuates on current and future demand for Pulmonary Drug Delivery Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.

Global Pulmonary Drug Delivery Devices Market Share by Region (Representative Graph)

Global Pulmonary Drug Delivery Devices Market Share

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the pulmonary drug delivery devices market include GlaxoSmithKline plc,Philips Respironics,Boehringer Ingelheim GmbH,Novartis AG,3M Healthcare,GF Health Products, Inc.,Merck & Co., Inc.,AstraZeneca. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
 
METHODOLOGY:

This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources,  Technical Journals, Financial Reports, SEC Filings, and other different industry publications. 

If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Market
       2.2. Global Market Snapshot
 
3 . PULMONARY DRUG DELIVERY DEVICES – INDUSTRY ANALYSIS
       3.1. Introduction - Market Dynamics
       3.2. Market Drivers
       3.3. Market Restraints
       3.4. Opportunities
       3.5. Industry Trends
       3.6. Porter’s Five Force Analysis
       3.7. Market Attractiveness Analysis
           3.7.1 By Product
           3.7.2 By Application
           3.7.3 By Distribution Channel
           3.7.4 By End-Use
           3.7.5 By Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Value Chain Analysis
       4.2. Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Raw Material Manufactures List
           4.2.3. Price Trend of Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
       5.5. COVID-19: Micro and Macro Factor Analysis
 
6 . GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET ANALYSIS BY PRODUCT
       6.1 Overview by Product
       6.2 Historical and Forecast Data
       6.3 Analysis by Product
       6.4 Metered Dose Inhalers Market by Regions
       6.6 Dry Powder Inhalers Market by Regions
       6.5 Nebulizers Market by Regions
       6.7 Accessories Market by Regions
 
7 . GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET ANALYSIS BY APPLICATION
       7.1 Overview by Application
       7.2 Historical and Forecast Data
       7.3 Analysis by Application
       7.4 Asthma Market by Regions
       7.5 Cystic Fibrosis Market by Regions
       7.6 COPD Market by Regions
       7.7 Allergic Rhinitis Market by Regions
       7.8 Others Market by Regions
 
8 . GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
       8.1 Overview by Distribution Channel
       8.2 Historical and Forecast Data
       8.3 Analysis by Distribution Channel
       8.4 Retail Pharmacies Market by Regions
       8.5 Hospital Pharmacies Market by Regions
       8.6 E-Commerce Market by Regions
 
9 . GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET ANALYSIS BY END-USE
       9.1 Overview by End-Use
       9.2 Historical and Forecast Data
       9.3 Analysis by End-Use
       9.4 Hospitals & Clinics Market by Regions
       9.5 Homecare Market by Regions
 
10 . GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET ANALYSIS BY GEOGRAPHY
       10.1. Regional Outlook
       10.2. Introduction
       10.3. North America
           10.3.1. Overview, Historic and Forecast Data
           10.3.2. North America By Segment
           10.3.3. North America By Country
           10.3.4. United State
           10.3.5. Canada
           10.3.6. Mexico
       10.4. Europe
           10.4.1. Overview, Historic and Forecast Data
           10.4.2. Europe by Segment
           10.4.3. Europe by Country
           10.4.4. United Kingdom
           10.4.5. France
           10.4.6. Germany
           10.4.7. Italy
           10.4.8. Russia
           10.4.9. Rest Of Europe
       10.5. Asia Pacific
           10.5.1. Overview, Historic and Forecast Data
           10.5.2. Asia Pacific by Segment
           10.5.3. Asia Pacific by Country
           10.5.4. China
           10.5.5. India
           10.5.6. Japan
           10.5.7. South Korea
           10.5.8. Australia
           10.5.9. Rest Of Asia Pacific
       10.6. Latin America
           10.6.1. Overview, Historic and Forecast Data
           10.6.2. Latin America by Segment
           10.6.3. Latin America by Country
           10.6.4. Brazil
           10.6.5. Argentina
           10.6.6. Peru
           10.6.7. Chile
           10.6.8. Rest of Latin America
       10.7. Middle East & Africa
           10.7.1. Overview, Historic and Forecast Data
           10.7.2. Middle East & Africa by Segment
           10.7.3. Middle East & Africa by Country
           10.7.4. Saudi Arabia
           10.7.5. UAE
           10.7.6. Israel
           10.7.7. South Africa
           10.7.8. Rest Of Middle East And Africa
 
11 . COMPETITIVE LANDSCAPE OF THE PULMONARY DRUG DELIVERY DEVICES COMPANIES
       11.1. Pulmonary Drug Delivery Devices Market Competition
       11.2. Partnership/Collaboration/Agreement
       11.3. Merger And Acquisitions
       11.4. New Product Launch
       11.5. Other Developments
 
12 . COMPANY PROFILES OF PULMONARY DRUG DELIVERY DEVICES INDUSTRY
       12.1. Company Share Analysis
       12.2. Market Concentration Rate
       12.3. GlaxoSmithKline plc
           12.3.1. Company Overview
           12.3.2. Financials
           12.3.3. Products
           12.3.4. Recent Developments
       12.4. Philips Respironics
           12.4.1. Company Overview
           12.4.2. Financials
           12.4.3. Products
           12.4.4. Recent Developments
       12.5. Boehringer Ingelheim GmbH
           12.5.1. Company Overview
           12.5.2. Financials
           12.5.3. Products
           12.5.4. Recent Developments
       12.6. Novartis AG
           12.6.1. Company Overview
           12.6.2. Financials
           12.6.3. Products
           12.6.4. Recent Developments
       12.7. 3M Healthcare
           12.7.1. Company Overview
           12.7.2. Financials
           12.7.3. Products
           12.7.4. Recent Developments
       12.8. GF Health Products, Inc.
           12.8.1. Company Overview
           12.8.2. Financials
           12.8.3. Products
           12.8.4. Recent Developments
       12.9. Merck & Co., Inc.
           12.9.1. Company Overview
           12.9.2. Financials
           12.9.3. Products
           12.9.4. Recent Developments
       12.10. AstraZeneca
           12.10.1. Company Overview
           12.10.2. Financials
           12.10.3. Products
           12.10.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  • COVID-19: Micro and Macro Factor Analysis
  • Analysis by Product (USD MN)
  • Metered Dose Inhalers Market by Geography (USD MN)
  • Dry Powder Inhalers Market by Geography (USD MN)
  • Nebulizers Market by Geography (USD MN)
  • Accessories Market by Geography (USD MN)
  • Analysis Market by Application (USD MN)
  • Asthma Market by Geography (USD MN)
  • Cystic Fibrosis Market by Geography (USD MN)
  • COPD Market by Geography (USD MN)
  • Allergic Rhinitis Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Analysis by Distribution Channel (USD MN)
  • Retail Pharmacies Market by Geography (USD MN)
  • Hospital Pharmacies Market by Geography (USD MN)
  • E-Commerce Market by Geography (USD MN)
  • Analysis by End-Use (USD MN)
  • Hospitals & Clinics Market by Geography (USD MN)
  • Homecare Market by Geography (USD MN)
  • Global Pulmonary Drug Delivery Devices Market by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
 
LIST OF FIGURES
 
  • Research Scope of Pulmonary Drug Delivery Devices Report
  • Market Research Process
  • Market Research Methodology
  • Global Pulmonary Drug Delivery Devices Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by Distribution Channel
  • Market Attractiveness Analysis by End-Use
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product (USD MN)
  • Metered Dose Inhalers Market by Geography (USD MN)
  • Dry Powder Inhalers Market by Geography (USD MN)
  • Nebulizers Market by Geography (USD MN)
  • Accessories Market by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Asthma Market by Geography (USD MN)
  • Cystic Fibrosis Market by Geography (USD MN)
  • COPD Market by Geography (USD MN)
  • Allergic Rhinitis Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Market Analysis by Distribution Channel (USD MN)
  • Retail Pharmacies Market by Geography (USD MN)
  • Hospital Pharmacies Market by Geography (USD MN)
  • E-Commerce Market by Geography (USD MN)
  • Global Market Analysis by End-Use (USD MN)
  • Hospitals & Clinics Market by Geography (USD MN)
  • Homecare Market by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Company Market Share Analysis, 2020
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials